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Abstract: Background: Alveolar hemorrhage can be seen in many vasculitic disorders. However, granulomatosis 
polyangiitis (formerly Wegener’s granulomatosis) uncommonly presents with life threatening alveolar hemorrhage and 
has only been discussed in a few case reports [1]. 
Case Presentation: A 53 year old Caucasian male presented with hemoptysis and profound anemia. Two weeks prior, he 
had presented with abdominal pain with normal renal function and numerous pulmonary nodules. During the current 
admission, the patient was hypoxic with acute renal failure requiring hemodialysis. Urine sediment demonstrated 
dysmorphic red blood cells. A bronchoscopy revealed diffuse alveolar hemorrhage. The diagnosis of pulmonary-renal 
syndrome was made and therapeutic plasma exchange was initiated. Laboratory studies were significant for a c-ANCA 
titer positive at 1:640 FIU and anti-proteinase (PR)-3 antibody titer positive with 78.3 U/ml. Renal biopsy demonstrated 
necrotizing crescentic glomerulonephritis. A diagnosis of granulomatosis vasculitis was determined. 
Conclusion: Alveolar hemorrhage is rare to be the presenting symptom of granulomatosis vasculitis where the common 
presenting features are recurrent sinusitis, epistaxis, chronic otitis media or rhinitis. Physicians should consider 
granulomatosis vasculitis in the differential diagnosis of pulmonary-renal syndrome presenting with hemoptysis. 
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INTRODUCTION 
 Granulomatosis polyangiitis is one of three pulmonary-
renal syndromes which are associated with antineutrophil 
cytoplasmic antibodies, either c-ANCA or p-ANCA, due to 
autoantibodies against target antigens proteinase-3 and 
myeloperoxidase (MPO), respectively. Classically, when a 
patient presents with pulmonary hemorrhage and necrotizing 
glomerulonephritis anti-glomerular basement membrane 
disease (anti-GBM disease) is thought of first. 
Granulomatosis polyangiitis is increasing in incidence and 
thus becoming aware and comfortable with the different 
clinical presentations of this disease process can be life 
saving. We describe a case of granulomatosis polyangiitis 
presenting with diffuse alveolar hemorrhage (DAH). 
CASE PRESENTATION 
 This case is a 53 year old Caucasian male with a history 
of tobacco abuse was over the past few months been treated 
twice with azithromycin and prednisone for what was 
believed to be bronchitis. Six weeks later he presented to the 
Emergency Department (ED) with abdominal pain. The  
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workup was significant for normal laboratory studies (Table 
1) and numerous pulmonary nodules, found on a chest x-ray 
and confirmed with a computed tomography scan (CT) of 
the chest. Subsequently, an outpatient positron-emission test 
(PET) scan showed metabolically active pulmonary nodules 
and a biopsy was scheduled. One week later and prior to the 
biopsy, he presented to the ED with hemoptysis. He was 
coughing black to bright red blood clots with whitish sputum 
for three days and, on the day of presentation, frank blood 
clots. He confirmed mild shortness of breath at rest and 
generalized weakness along with nausea and vomiting. He 
denied hematemesis. The patient worked as a maintenance 
worker and welder and had no history of exposure to 
 
Table 1. Laboratory Findings from Two Weeks Prior to 
Current Admission 
 
Laboratory Value Normal Value 
Hemoglobin 12 g/dL 13-18 g/dL 
Hematocrit 32% 40-52% 
Potassium 3.9 mEq/L 3.5-5 mEq/L 
BUN 22 mg/dL 6-20 mg/dL 
Creatinine 1.1 mg/dL 0.6-1.2 mg/dL 
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asbestos. Moreover, he had no recent travel outside the 
United States or sick contacts and NSAIDs on occasion He 
denied fever, chills, weight loss, loss of appetite, chest pain, 
abdominal pain, diarrhea, constipation, hematuria, changes 
in urine output, headaches, and rashes. 
 On examination, the patient was pale, afebrile with a 
blood pressure of 147/82 mmHg and tachycardic at 120 
beats per minute. He was hypoxic (pulse oximtery reading of 
83% on room air) and tachypneic (respiratory rate of 30 
breaths per minute). The examination was also significant 
for coarse breath sounds bilaterally in all lung fields and 
generalized poor air movement. 
 Initial laboratory studies were significant for profound 
anemia and acute renal failure (Table 2). Urine sediment 
Table 2. Laboratory Findings from this Admission 
 
Laboratory Value Normal Value 
White Blood Cell 15 k/uL 4.5-11 k/uL 
Hemoglobin 5.7 g/dL 13-18 g/dL 
Hematocrit 16.1% 40-52% 
Platelets 185 k/uL 150-440 k/uL 
Sodium 132 mEq/L 135-145 mEq/L 
Potassium 7.1 mEq/L 3.5-5 mEq/L 
Chloride  102 mEq/L 99-19 mEq/L 
Bicarbonate 18 mEq/L 22-33 mEq/L 
BUN 208 mg/dL 6-20 mg/dL 
Creatinine 12.11 mg/dL 0.6-1.2 mg/dL 
Glucose 121 mg/dL 70-105 mg/dL 
Calcium 8.7 mg/dL 8.5-10.5 mg/dL 
Phosphorus 10.3 mg/dL 2.9-4.8 mg/dL 
Magnesium 2.1 mg/dL 1.6-2.6 mg/dL 
AST 9 U/L 10-37 U/L 
ALT 12 U/L 10-49 U/L 
Alkaline Phosphatase 63 U/L 41-120 U/L 
Total bilirubin 0.4 mg/dL 0.3-1.2 mg/dL 
Total protein 6 g/dL 6.2-8.3 g/dL 
Albumin 2.8 g/dL 3.4-4.9 g/dL 
Lactate dehydrogenase 256 U/L 118-273 U/L 
Ferritin 782 ng/mL 22-322 ng/mL 
Transferrin 144 mg/dL 203-362 mg/dL 
Haptoglobin 146 mg/dL 40-240 mg/dL 
Iron 22 ug/dL 35-194 ug/dL 
Iron Binding Capacity 209 ug/dL 250-450 ug/dL 
Transferrin Saturation 11% 20-50% 
Complement C3 128 mg/dL 90-170 mg/dL 
Complement C4 27 mg/dL 12-36 mg/dL 
INR 1.0  
PT 10.6 seconds 9.7-11.3 seconds 
aPTT 27.5 seconds 23-31 seconds 
Urine analysis Cloudy, Straw, specific gravity 1.010, pH 5, 2+ proteins, 
negative glucose, negative ketones, negative bilirubin, 
too numerous to count RBCs, 3+ hemoglobin, no WBC, 
negative leukocyte esterase, negative nitrites, normal 
urobilinogen, amorphous sediment 
Clear, Yellow, specific gravity 1.005-1.030, pH 4.5-8, 
negative proteins, negative glucose, negative ketones, 
negative bilirubin, 0/HPF RBCs, negative hemoglobin, 
0/HPF WBC, negative leukocyte esterase, negative 
nitrites, normal urobilinogen 
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demonstrated a moderate amount of dysmorphic red blood 
cells (RBC) with no RBC casts but a moderate amount of 
muddy brown casts. The chest x-ray (Fig. 1) showed diffuse 
bilateral airspace opacities that were non-specific concerning 
for pulmonary edema, pulmonary hemorrhage, ARDS, or 
pneumonia. Given the presence of hemoptysis, urinary red 
cell casts and acute kidney injury, the possibility of a 
pulmonary-renal syndrome was considered. He was 
intubated and placed on mechanical ventilation and bronchial 
lavage was initially sent from the patient confirming 
pulmonary hemorrhage seen in Fig. (2). The patient was 
started on a course of plasmapheresis and supportive 
hemodialysis. Immunologic studies were done and are 
reflected in Table 3. Significant findings included c-ANCA 
titer of 1:640 FIU, and a negative anti-GBM antibody titer. A 
renal biopsy was performed and was significant for 
necrotizing crescentic glomerulonephritis with fibrocellular 
crescents in nine of sixteen glomeruli along with acute 
tubular injury (Figs. 3, 4) with a lung biopsy (Figs. 5-7) 
indicating the presence of acute and organizing infarct with 
numerous vascular thrombi and necrotizing vasculitis. 
 
Fig. (1). Portable upright AP view showing diffuse bilateral 
airspace opacities. Differential diagnosis includes pulmonary 
edema, pulmonary hemorrhage, ARDS, and pneumonia. 
 The definitive diagnosis of granulomatosis polyangiitis 
was made. As the diagnosis was being confirmed renal 
replacement therapy was begun as well as four treatments of 
plasmapharesis were completed. Once the diagnosis was 
confirmed, plasmapharesis was stopped and the patient was 
started on cyclophosphamide and prednisone along with 
dialysis support. Immunologically he achieved remission, 
but failed to recover renal function and remains dependent 
on hemodialysis (Graph 1). 
DISCUSSION 
 Granulomatosis polyangiitis is a pauci-immune 
vasculitis, and is one of the many causes of pulmonary-renal 
syndrome. Etiologies of pulmonary-renal syndrome include 
anti-GBM disease, and microscopic polyangiitis (MPA), and 
granulomatosis polyangiitis. This patient’s clinical 
presentation of DAH with necrotizing crescentic 
glomerulonephritis was atypical but immunologically 
consistent with granulomatosis polyangiitis due to high titers 
of c-ANCA and PR-3 antibodies. 
 The incidence of granulomatosis polyangiitis has almost 
doubled from since 1990 to 1 in 64.8 million in 2005 and 
mean age range at presentation is 40 to 60 years [2]. 
Granulomatosis polyangiitis is a systemic vasculitis that 
affects both medium and small vessels. Typically, 
granulomatosis polyangiitis involves the upper respiratory 
tract, lungs, kidneys and joints and is frequently an indolent 
disease [3]. Most of these patients have c-ANCA positive 
antibodies and less commonly myeloperioxidase positive 
antibodies [4]. Approximately 99% of patients with 
granulomatosis polyangiitis will develop upper respiratory 
tract involvement during the disease process [2,4]. 
Pulmonary involvement ranges from 60-85%, classically as 
capillaritis or granulomatosis masses, which could lead to 
diffuse alveolar hemorrhage (DAH) [2]. DAH has been 
reported over a wide range from 7-40%, and usually the 
results of a mass or untreated capillaritis [4,6]. DAH is 
characteristically not the presenting symptom, as seen in our  
 
Table 3. Immunologic Studies 
 
Laboratory Value Normal Value 
Antinuclear antibody < 7.5 IU/mL < 7.5 IU/mL 
Antineutrophil cytoplasmic Antibody Total: ≥ 1:640 FIU 
c-ANCA pattern 
Total: < 1:20 FIU 
Glomerular Basement Membrane Antibody < 1.0 AI < 1.0 AI 
Total Hepatitis B Core Antibody Negative Negative 
Hepatitis B Surface Antigen Antibody Postitive  
Hepatitis C Virus Antibody Negative Negative 
Neutrophil Myeloperoxidase Antibody < 9.0 U/mL < 9.0 U/mL 
Neutrophil Proteinase-3 Autoantibody 78.3 U/mL < 3.5 U/mL 
Rheumatoid Factor 80 IU/mL < 10 IU/mL 
Anti-Streptolysin (ASO) Antibody 53 IU/mL ≤ 200 IU/mL 












Fig. (2). Bronchial lavage showing hemosiderin laden macrophages with an index of 77% indicative of pulmonary hemorrhage seen on light 
microscopy with magnification at 40x with an iron stain. 
 
Fig. (3). Kidney biopsy showing necrotizing glomerulonephritis in the glomerulus with crescents seen on light microscopy with 
magnification at 20x with a hematoxylin and eosin stain. 


















Fig. (4). Kidney biopsy shows glomerular tuft rupture seen on light microscopy with magnification at 20X with a Jones methenamine silver 
stain. 
 
Fig. (5). Lung biopsy shows a necrotizing vasculitis that is associated with hemorrhagic infarct in the lung parenchyma seen with light 
microscopy with magnification at 10x with a hematoxylin and eosin stain. 
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case. It has been agreed upon that DAH does have an 
increase mortality rate of 60%, however, if granulomatosis 
polyangiitis is left untreated the mortality rate is 91% [1,5,7-
9]. 
 
 Glomerulonephritis is also been reported in varying 
frequencies from 40-70% [2]. Typically only about 25% 
require dialysis and only half of those will progress to end-
stage renal disease [1,2]. Severe renal disease has been 
 
Fig. (6). Lung biopsy shows vascular thrombi in the lung seen with light microscopy with magnification at 4x with a hematoxylin and eosin 
stain. 
 
Fig. (7). Lung biopsy shows necrotizing vasculitis that is associated with hemorrhagic infarct seen with light microscopy with magnification 
at 10x with a hematoxylin and eosin stain. 
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classified by the European Vasculitis Study Group as a 
presenting creatinine of over 5.8mg/dL [12]. Persistent renal 
impairment despite adequate treatment also leads to poor 
prognosis [2]. 
 The prognosis of vasculitic disease is worse with 
concomitant renal impairment and pulmonary manifestations 
at initial presentation with the absence of upper respiratory 
tract involvement [2]. Those individuals that are admitted to 
the intensive care unit (ICU) with a suspected alveolar 
hemorrhage have a mortality of 25 to 50% [4]. Therefore, it 
is imperative to have a high index of suspicion in order to 
improve the outcomes. This disease is often confused with 
anti-GBM disease or microscopic polyangiitis (MPA). The 
only way to differentiate these diseases is by serology testing 
and confirmed with either lung or kidney biopsy. 
Goodpasture’s syndrome is associated with high titers of 
anti-GBM antibody and DAH is a common presenting 
symptom. Goodpasture’s disease is treated with 
plasmapheresis. MPA typically presents with capillaritis then 
subsequently develops Granulmatous vasculitis, but these 
diseases are treated very similarly with glucocorticoids and 
cyclophosphamide. However, in the presence of diffuse 
alveolar hemorrhage, immunosuppressive therapy alone can 
be inadequate and therefore plasmapheresis is instituted in 
some cases. There has been a randomized study that has 
shown benefit with plasmapharesis in addition to 
immunosuppressive therapy which includes the traditional 
high dose methylprednisolone with patients in severe renal 
diseae [12]. Due to the high mortality rate, associated with 
DAH and severe renal disease, our patient was 
plasmapheresed even before intravenous cyclophosphamide 
and glucocortiocoids were given and biopsy results were 
available. Recent evidence suggests that patients with severe 
ANCA-associated vasculitis, defined by the presence of 
DAH and/or severe renal involvement (creatinine greater 
than 5.7 mg/dL), might benefit from this combination 
[5,10,11]. 
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